In Silico Docking Studies of Selected Flavonoids - Natural Healing Agents against Breast Cancer |
Suganya, Jeyabaskar
(Department of Bioinformatics, School of Life Sciences, Vels University)
Radha, Mahendran (Department of Bioinformatics, School of Life Sciences, Vels University) Naorem, Devi Leimarembi (Department of Bioinformatics, School of Life Sciences, Vels University) Nishandhini, Marimuthu (Department of Bioinformatics, School of Life Sciences, Vels University) |
1 | Ariazi EA, Ariazi JL, Cordera F, Jordan VC (2006). Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem, 6, 181-202. DOI |
2 | Andrew NF, Binbing Y, Mitchell HG, et al (2011). Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol, 29, 2327-33. DOI |
3 | Binkowski TA, Naghibzadeh S, Liang J (2003). CASTp: Computed atlas of surface topography of proteins. Nucleic Acids Res, 31, 3352-55. DOI |
4 | Batra P, Sharma AK (2013). Anti-cancer potential of favonoids: recent trends and future Perspectives. Biotech, 3, 439-59. |
5 | Benson JR, Jatoi I (2012). The global breast cancer burden. Future Oncol, 8, 697-702. DOI |
6 | Berman HM, Battistuz T, Bhat TN, et al (2002). The protein data bank. Acta Crystallogr D Biol Crystallogr, 58, 899-907. DOI |
7 | Chi F, Wu R, Zeng Y-C, et al (2013). Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev, 14, 2407-12. DOI |
8 | Chitrala KN, Yeguvapalli S (2013). Prediction and analysis of ligands against estrogen related receptor alpha. Asian Pac J Cancer Prev, 14, 2371-5. DOI |
9 | Dickson RB, Stancel GM (2000). Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr, 27, 135-45. |
10 | Dykstra KD, Guo L, Birzin ET, et al (2007). Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERalpha. Bioorg Med Chem Lett, 17, 2322-8. DOI |
11 | Fabian CJ, Kimler BF (2001). Chemoprevention for high-risk women: tamoxifen and beyond. Breast J, 7, 311-20. DOI |
12 | Fuqua SA (2001). The role of estrogen receptors in breast cancer metastasis. J Mammary Gland Biol Neoplasia, 6, 407-17. DOI |
13 | Galluzzo P, Marino M (2006). Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities. Genes Nutrition, 1, 161-76. DOI |
14 | Izadi P, Noruzinia M, Fereidooni F, Nateghi MR (2012). Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women. Asian Pac J Cancer Prev, 13, 4113-7. DOI ScienceOn |
15 | Jarzabek K, Koda M, Kozlowski L, et al (2009). The significance of the expression of ERRalpha as a potential biomarker in breast cancer. J Steroid Biochem Mol Biol, 113, 127-133. DOI |
16 | Hayashi S, Eguchi H, Tanimoto K et al (2003). The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat cancer, 10, 193-202. DOI |
17 | Hui C, Qi X, Qianyong Z, et al (2013). flavonoids, flavonoid subclasses and breast cancer risk: A meta-analysis of epidemiologic studies. Plus One, 8, 54318. DOI |
18 | Karimi Zarchi M, Behtash N, Sekhavat L, Dehghan A (2009). Effects of tamoxifen on the cervix and uterus in women with breast cancer: experience with iranian patients and a literature review. Asian Pac J Cancer Prev, 10, 595-8. |
19 | Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M (1999). Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem, 63, 896-9. DOI ScienceOn |
20 | Kumar P, Bolshette NB, Jamdade VS, et al (2013). Breast cancer status in India. Biomedicine Preventive Nutrition, 3, 177-83. DOI |
21 | Limer JL, Speirs V (2004). Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res, 6, 119-27. DOI ScienceOn |
22 | Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46, 3-26. DOI ScienceOn |
23 | Park WC, Jordan VC (2002). Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends Mol Med, 8, 82-8. DOI |
24 | Lu H, Chen D, Hu L-P, et al (2013). Estrogen receptor alpha gene polymorphisms and breast cancer risk: a case-control study with meta-analysis combined. Asian Pac J Cancer Prev, 14, 6743-9. DOI |
25 | Miller PE, Snyder DC (2012). Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Pract, 27, 599-612. DOI |
26 | Oda A, Kamiyama Y, Yoshida T, et al (2007). Evaluation of docking accuracy and investigations of roles of parameters and each term in scoring functions for protein-ligand docking using Argus lab software. Bull Chem Soc Jap, 80, 1920-5. DOI |
27 | Parkkari M, Paakkala AM, Salminen L, Holli K (2003). Ocular side effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study. Acta Ophthalmol Scand, 81, 495-9. DOI |
28 | Pouget C, Lauthier F, Simon A, et al (2001). flavonoids: Structural requirements for antiproliferative activity on breast cancer cells. Bioorg Med Chem Lett, 11, 3095-7. DOI ScienceOn |
29 | Ramezani F, Salami S, Omrani MD, Maleki D (2012). CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Asian Pac J Cancer Prev, 13, 451-7. DOI ScienceOn |
30 | Pritchard KI (2001). Breast cancer prevention with selective estrogen receptor modulators: a perspective. Ann NY Acad Sci, 949, 89-98. |
31 | Salih AK, Fentiman IS (2001). Breast cancer prevention: present and future. Cancer Treat Rev, 27, 261-73. DOI |
32 | Stapel J, Oppermann C, Richter DU, Ruth W, Briese V (2013). Polyphenol compounds with anti-carcinogenic qualities: Effects of quercetin (flavonol), chrysin (flavon), kaempferol (flavanol), naringenin (flavanon) and hesperidin (flavanoid) on in vitro breast cancer. J Med Plants Res, 7, 2187-96. |
33 | Sanaz Hamedeyazdan, Fatemeh F, Simin Sharifi, Nazemiyeh H (2012). Antiproliferative activity of marrubium persicum Extract in the MCF-7 human breast cancer cell line. Asian Pac J Cancer Prev, 13, 5843-8. DOI |
34 | Shi J, Ji A, Cao Z, et al (2011). Equol induced apoptosis of human breast cancer MDA-MB-231 cell by inhibiting the expression of nuclear factor-kappaB, Wei Sheng Yan Jiu, 40, 95-8. |
35 | Shuzhong Zhang, Xinning Yang, Marilyn E Morris (2004). flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol, 65, 1208-16. DOI ScienceOn |
36 | Thomas C, Gustafsson JA (2011). The different roles of ER subtype in cancer biology and therapy. Nature Reviews Cancer, 11, 597-608. DOI |
37 | Toniti W, Suthiyotha N, Puchadapirom P, Jenwitheesuk E (2011). Binding capacity of ER-, ligands and SERMs: comparison of the human, dog and cat. Asian Pac J Cancer Prev, 12, 2875-9. |
38 | Xu C-Y, Jiang Z-N, Zhou Y, Li J-J, Huang L-M (2013). Estrogen receptor roles in breast cancer chemoresistance. Asian Pac J Cancer Prev, 14, 4049-52. DOI ScienceOn |